biomarin pharmaceutical ceo on the company's drug pricing strategy
Published 1 year ago • 1K plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
5:12
biomarin pharmaceuticals ceo | mad money | cnbc
-
6:14
biomarin pharmaceutical ceo: orphan opportunity? | mad money | cnbc
-
7:17
biomarin ceo: rare treatments, high costs | mad money | cnbc
-
6:57
biomarin pharmaceutical ceo: substantial profits ahead | mad money | cnbc
-
5:19
biomarin pharmaceutical ceo: treating hemophilia | mad money | cnbc
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
4:10
buy or bail on biotech: here's what you need to know
-
5:09
cytokinetics ceo on shares soaring, heart drug aficamten and american heart health
-
6:01
biomarin pharmaceutical ceo: close to a cure? | mad money | cnbc
-
5:51
biomarin ceo: biotech breakthrough? | mad money | cnbc
-
5:55
biomarin ceo jean-jacques bienaimé: pipeline profits?| mad money | cnbc
-
2:41
biomarin ceo: study results for hemophilia gene therapy are as 'good as we could hope'
-
2:51
how this $1.8 million drug is trying to disrupt the drug pricing system
-
7:25
biomarin ceo expects 'substantial' profitability after fda approval of hemophilia drug
-
3:07
drug pricing in focus as biopharma sector reports earnings
-
7:30
alder biopharmaceuticals ceo: is the tide turning? | mad money | cnbc
-
48:52
finding tomorrows: full film
-
6:09
alder biopharmaceuticals ceo: a stock on fire | mad money | cnbc
-
7:45
innovent biologics ceo on pharma industry, prices, pipeline, cancer cure
-
6:50
biomarin ceo: there are biotech companies 'that probably should not be on the market today’
-
1:41
phrma president and ceo on drug pricing